Cupid shares experienced a sharp 20% decline on Monday before recovering while the company raised its FY27 revenue and profit forecasts, bolstered by strong order books and international growth prospects. The stock remains one of 2026’s top performers, with a 155% gain this year and 688% over the past 12 months.
Cupid shares swung sharply on Monday, falling as much as 20% to ₹235 before recovering part of the loss to close at ₹268. Even after the turbulence, the stock remains one of the year’s biggest gainers, up 155% in 2026 and 688% over the past 12 months, according to Business Today’s report.
The move came after the consumer wellness and personal care company lifted its FY27 outlook, saying it now expects revenue of ₹725 crore to ₹750 crore and profit of ₹210 crore to ₹225 crore. The company attributed the higher guidance to a strong order book, steady momentum in its international B2B healthcare business and continued expansion in its consumer healthcare and FMCG range. In the June quarter, Cupid reported net profit of ₹44.15 crore, up 194% from a year earlier, while revenue climbed 142% to ₹156.98 crore. EBITDA more than tripled to ₹60.06 crore and margins improved to 39%, the company said.
Cupid has also pointed to a stronger pipeline in its IVD kits business, saying earlier this month that it expects sizeable orders from several Indian state governments and fresh overseas opportunities after securing CE certifications, the company said during its quarterly results update. It added that multiple deals were in the final stages of approval, supporting near-term growth prospects.
Separately, Baazar Style Retail rose 5% to ₹384.45 after a block deal in which 45 lakh shares worth ₹162.90 crore changed hands at ₹362 each, equal to 5.3% of the company’s outstanding shares. The buyer and seller were not immediately identified, but CNBC-TV18 reported that Cupid chairman Aditya Halwasiya was likely the buyer. BSE shareholding data showed Halwasiya held a 33.29% stake in Cupid at the end of the June quarter.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
